Search

for
Search:

Glossary

Similar Terms

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Polycystic Ovary Syndrome: Etiology, Pathogenesis, and Diagnosis

991 citations , January 2011 in “Nature Reviews Endocrinology”

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

research PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist

5 citations , April 2013 in “Current Problems in Pediatric and Adolescent Health Care”

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

research An Overview of Harmful Effects of Polycystic Ovary Syndrome

December 2021 in “Journal of oncology research reviews & reports”

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

research Polycystic Ovary Syndrome and Its Impact on Health

69 citations , November 2010 in “Middle East Fertility Society Journal”

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

research Results of Using Combined Oral Contraceptives with Drospirenone and Finasteride in Women with Polycystic Ovary Syndrome Without Metabolic Disorders

January 2011 in “Practical medicine”

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

View more "endometrial abnormalities" in research →

Community Join

3 / 3 results

community Taking Charge of Your Hair: The "Big 3 Stack" Explained for 2023

in Research/Science 130 upvotes 2 years ago

The "Big 3 Stack" for hair loss treatment, which includes Minoxidil for hair density improvement, Ketoconazole shampoo for enhancing hair volume and thickness, and Finasteride for blocking hair loss causing hormones. Microneedling can boost Minoxidil's effects.

community The story of RU58841/ PSK3841

in Research 622 upvotes 1 year ago

RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

community Results are in for my experiment with Creatine/Fin

in Finasteride 130 upvotes 6 years ago

Creatine use with finasteride increased DHT levels, possibly affecting hair loss. The user plans to reduce creatine to stabilize DHT and hair shedding.